The combined use of opioids for migraine and triptans or SSRIs/SNRIs for depression can result in serotonin syndrome, which produces symptoms that range from mild to severe to potentially life-threatening.
Which medications have been linked to idiopathic intracranial hypertension? Take the quiz and learn more.
Nearly a decade in the making, revised guidelines provide 8 key points for effective nonpharmacologic treatment of epilepsy in childhood.
A study examined the effects of resistance training, aerobic exercise, mind-body, or any combination of these exercises on cognitive function in older adults.
From documentaries to dramas, these movies expose the hidden disability of epilepsy through film and shed light on the topic, potentially helping patients better understand their illness.
A large study reveals a quality diet leads to larger brain tissue volumes, suggesting that nutrition has an effect on neurodegeneration via brain structure.
Eighteen percent of all improperly used thrombolytic treatments in the emergency department occur in patients with migraine with aura.
Mode of delivery, mechanism of action, and efficacy of a novel treatment are discussed in this research update.
The FDA has approved a new drug for the prevention of migraines. Will the injectable treatment help reduce the number of days of migraine headaches?
Because of the increased incidence of stroke that is sometimes observed with HRT, neurologists are often asked to consult with prescribing physicians to assess stroke risk.
What are the key symptoms of TIND, a rare condition that can occur after rapid normalization of blood glucose levels following prolonged periods of hyperglycemia?
How effective is the telemedicine versus telephonic approach in acute care?
New research may help doctors determine when (and when not) to test for antiglutamate decarboxylase antibodies in patients with neurological disorders and psychiatric symptoms.
Are AEDs safe for children? Take the quiz and learn more.
A new study has found that patients with neuropsychiatric systemic lupus erythematosus have 3 times increased risk of death, and this risk increases to over 7 times higher in patients with focal CNS symptoms.